Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q20077596> ?p ?o }
Showing triples 1 to 49 of
49
with 100 triples per page.
- Q20077596 subject Q7334131.
- Q20077596 subject Q8220082.
- Q20077596 subject Q8503312.
- Q20077596 subject Q8949762.
- Q20077596 subject Q8965786.
- Q20077596 abstract "Roxatidine acetate is a specific and competitive histamine H2 receptor antagonist drug that is used to treat gastric ulcers, Zollinger–Ellison syndrome, erosive esophagitis, gastro-oesophageal reflux disease, and gastritis.Pharmacodynamic studies showed that 150 mg of roxatidine acetate were optimal in suppressing gastric acid secretion, and that a single bedtime dose of 150 mg was more effective than a dose of 75 mg twice daily in terms of inhibiting nocturnal acid secretion.It is available in countries including China, Japan, Korea, Germany, Italy, the Netherlands, Greece and South Africa.".
- Q20077596 atcPrefix "A02".
- Q20077596 atcSuffix "BA06".
- Q20077596 bioavailability "80.0".
- Q20077596 casNumber "78628-28-1".
- Q20077596 drugbank "DB08806".
- Q20077596 fdaUniiCode "IV9VHT3YUM".
- Q20077596 iupacName "2-oxo-2-(3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino)ethyl acetate".
- Q20077596 pubchem "5105".
- Q20077596 thumbnail Roxatidine_acetate.svg?width=300.
- Q20077596 wikiPageWikiLink Q14864427.
- Q20077596 wikiPageWikiLink Q14874295.
- Q20077596 wikiPageWikiLink Q172941.
- Q20077596 wikiPageWikiLink Q183130.
- Q20077596 wikiPageWikiLink Q218712.
- Q20077596 wikiPageWikiLink Q223591.
- Q20077596 wikiPageWikiLink Q298230.
- Q20077596 wikiPageWikiLink Q409444.
- Q20077596 wikiPageWikiLink Q725307.
- Q20077596 wikiPageWikiLink Q7334131.
- Q20077596 wikiPageWikiLink Q796604.
- Q20077596 wikiPageWikiLink Q8220082.
- Q20077596 wikiPageWikiLink Q846270.
- Q20077596 wikiPageWikiLink Q8503312.
- Q20077596 wikiPageWikiLink Q8949762.
- Q20077596 wikiPageWikiLink Q8965786.
- Q20077596 wikiPageWikiLink Q9368.
- Q20077596 wikiPageWikiLink Q9377.
- Q20077596 atcPrefix "A02".
- Q20077596 atcSuffix "BA06".
- Q20077596 bioavailability "80".
- Q20077596 casNumber "78628".
- Q20077596 drugbank "DB08806".
- Q20077596 iupacName "2".
- Q20077596 pubchem "5105".
- Q20077596 unii "IV9VHT3YUM".
- Q20077596 type ChemicalSubstance.
- Q20077596 type Drug.
- Q20077596 type ChemicalObject.
- Q20077596 type Thing.
- Q20077596 type Q8386.
- Q20077596 comment "Roxatidine acetate is a specific and competitive histamine H2 receptor antagonist drug that is used to treat gastric ulcers, Zollinger–Ellison syndrome, erosive esophagitis, gastro-oesophageal reflux disease, and gastritis.Pharmacodynamic studies showed that 150 mg of roxatidine acetate were optimal in suppressing gastric acid secretion, and that a single bedtime dose of 150 mg was more effective than a dose of 75 mg twice daily in terms of inhibiting nocturnal acid secretion.It is available in countries including China, Japan, Korea, Germany, Italy, the Netherlands, Greece and South Africa.".
- Q20077596 label "Roxatidine acetate".
- Q20077596 depiction Roxatidine_acetate.svg.